Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16879746rdf:typepubmed:Citationlld:pubmed
pubmed-article:16879746lifeskim:mentionsumls-concept:C0041455lld:lifeskim
pubmed-article:16879746lifeskim:mentionsumls-concept:C0011644lld:lifeskim
pubmed-article:16879746lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:16879746pubmed:issue4lld:pubmed
pubmed-article:16879746pubmed:dateCreated2007-1-16lld:pubmed
pubmed-article:16879746pubmed:abstractTextThis study was conducted to examine the frequency, phenotype, and functional profile of T lymphocytes that proliferate in response to type I collagen (CI) in patients with scleroderma (SSc). Peripheral blood mononuclear cells (PBMCs) from SSc patients, healthy controls, and rheumatoid arthritis disease controls were labeled with carboxy-fluorescein diacetate, succinimidyl ester (CFSE), cultured with or without antigen (bovine CI) for 14 days, and analysed by flow cytometry. Surface markers of proliferating cells were identified by multi-color flow cytometry. T-cell lines were derived after sorting for proliferating T cells (CFSElow). Cytokine expression in CI-responsive T cells was detected by intracellular staining/flow cytometry and by multiplex cytokine bead assay (Bio-Plex). A T-cell proliferative response to CI was detected in 8 of 25 (32%) SSc patients, but was infrequent in healthy or disease controls (3.6%; p = 0.009). The proliferating T cells expressed a CD4+, activated (CD25+), memory (CD45RO+) phenotype. Proliferation to CI did not correlate with disease duration or extent of skin involvement. T-cell lines were generated using in vitro CI stimulation to study the functional profile of these cells. Following activation of CI-reactive T cells, we detected intracellular interferon (IFN)-gamma but not interleukin (IL)-4 by flow cytometry. Supernatants from the T-cell lines generated in vitro contained IL-2, IFN-gamma, GM-CSF (granulocyte macrophage-colony-stimulating factor), and tumour necrosis factor-alpha, but little or no IL-4 and IL-10, suggesting that CI-responsive T cells express a predominantly Th1 cytokine pattern. In conclusion, circulating memory CD4 T cells that proliferate to CI are present in a subset of patients with SSc, but are infrequent in healthy or disease controls.lld:pubmed
pubmed-article:16879746pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:languageenglld:pubmed
pubmed-article:16879746pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:citationSubsetIMlld:pubmed
pubmed-article:16879746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16879746pubmed:statusMEDLINElld:pubmed
pubmed-article:16879746pubmed:issn1478-6362lld:pubmed
pubmed-article:16879746pubmed:authorpubmed-author:KangAndrew...lld:pubmed
pubmed-article:16879746pubmed:authorpubmed-author:WarringtonKen...lld:pubmed
pubmed-article:16879746pubmed:authorpubmed-author:NairUshaUlld:pubmed
pubmed-article:16879746pubmed:authorpubmed-author:Postlethwaite...lld:pubmed
pubmed-article:16879746pubmed:authorpubmed-author:CarboneLaura...lld:pubmed
pubmed-article:16879746pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16879746pubmed:volume8lld:pubmed
pubmed-article:16879746pubmed:ownerNLMlld:pubmed
pubmed-article:16879746pubmed:authorsCompleteYlld:pubmed
pubmed-article:16879746pubmed:paginationR136lld:pubmed
pubmed-article:16879746pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:meshHeadingpubmed-meshheading:16879746...lld:pubmed
pubmed-article:16879746pubmed:year2006lld:pubmed
pubmed-article:16879746pubmed:articleTitleCharacterisation of the immune response to type I collagen in scleroderma.lld:pubmed
pubmed-article:16879746pubmed:affiliationDepartment of Medicine, Division of Connective Tissue Diseases, 956 Court Avenue, Room G326, Memphis, TN 38163, USA. warrington.kenneth@mayo.edulld:pubmed
pubmed-article:16879746pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16879746pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:16879746pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16879746pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed